Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab. Arthritis Rheumatol. 2017 03; 69(3):643-654.

View in: PubMed

subject areas

Adolescent
Adolescent
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
B-Cell Activating Factor
B-Cell Activating Factor
Double-Blind Method
Double-Blind Method
Female
Female
Gene Expression
Gene Expression
Humans
Humans
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Male
Male
Middle Aged
Middle Aged
Young Adult
Young Adult

authors with profiles

Joan Merrill